Nike Total Cost of Revenue decreased by 8.6% to $6.75B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $6.59B to $6.75B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a 1.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.69B | $6.55B | $6.14B | $5.80B | $6.73B | $7.07B | $7.60B | $7.02B | $7.23B | $7.22B | $7.42B | $6.87B | $6.97B | $6.33B | $6.97B | $6.59B | $6.63B | $6.78B | $7.38B | $6.75B |
| QoQ Change | — | -2.0% | -6.2% | -5.5% | +16.0% | +5.1% | +7.5% | -7.7% | +3.0% | -0.2% | +2.7% | -7.4% | +1.5% | -9.2% | +10.0% | -5.3% | +0.5% | +2.2% | +8.9% | -8.6% |
| YoY Change | — | — | — | — | +0.6% | +7.9% | +23.8% | +20.9% | +7.4% | +2.1% | -2.5% | -2.2% | -3.6% | -12.3% | -6.1% | -4.0% | -4.9% | +7.0% | +6.0% | +2.4% |